Value
In today's fast-changing world, staying competitive requires more than operational excellence — it demands a visionary approach. Our Board of Advisors brings:
Helping QbD Group scale and innovate with deep sector knowledge.
Challenging and refining our strategies with an objective perspective.
Facilitating collaborations and partnerships across the life sciences industry.
Guiding companies through growth, transformation, and long-term success.
Support
The Board of Advisors has been formed to offer strategic counsel to QbD Group's leadership, helping us navigate the evolving life sciences landscape.
By leveraging their expertise in international business growth, mergers & acquisitions, scientific advancements, and industry best practices, they provide an invaluable external perspective.
The board
The Board of Advisors is composed of distinguished professionals, each bringing their unique experiences and perspectives to QbD Group.
Adam has nearly 40 years of experience in the life sciences sector, leading professional services, technology, consultancy, and outsourcing companies. As CEO of multiple private equity-backed firms, he has driven remarkable growth and value creation.
"I'm honored to be part of QbD Group's exciting journey and look forward to helping them navigate new opportunities and challenges in the evolving life sciences market."
Mark brings more than 35 years of experience in pharmaceutical development and commercialization. As the former CEO of Quotient Sciences, he led an extraordinary phase of growth, significantly increasing revenue and shareholder value.
"I'm excited to contribute to QbD Group's continued success, helping them turn their innovative solutions into real value for the global life sciences community."
QbD Group awarded Platinum label as Best Managed Company 2026, marking seven consecutive years of recognition for excellence in the life sciences industry.
Read more
At QbD Group, we are joining forces with Vigintake to support the evolution of pharmacovigilance operations through intelligent automation and innovative digital solutions, combining regulatory expertise, quality systems, and advanced technology.
Read more
QbD Group today announces the acquisition of Rescop, a specialist in GxP compliance, computer system validation, and validation software for the life sciences industry.
Read more
QbD Group has been recognized with the AEFI Award for Best Publication of 2025 for the article "Pharmacovigilance in innovative therapies: Regulatory and clinical challenges," authored by Almudena del Castillo, Head of Global Vigilance Division and Country Manager Spain.
Read more
QbD Group & delaware announce a new partnership to help life sciences companies accelerate their digital transformation while ensuring full GxP compliance.
Read more
QbD Group joins ASEBIO, strengthening its commitment to quality, compliance, and safety within the Spanish life sciences sector.
Read more
QbD Group has been awarded the title of Best Pharmacovigilance Service Company at the latest edition of Farmaforum.
Read more
QbD Group welcomes Dr. Diane Fairweather as Division Head Clinical, with 25+ years in global clinical leadership to strengthen and scale the division.
Read more
Let our experts help you navigate the complexities of life sciences regulation and quality.
